- Home
- PBF vs RYTM Comparison
PBF vs RYTM Comparison
Compare PBF & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBF
- RYTM
- Stock Information
- Founded
- PBF 2008
- RYTM 2008
- Country
- PBF United States
- RYTM United States
- Employees
- PBF N/A
- RYTM N/A
- Industry
- PBF Integrated oil Companies
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- PBF Energy
- RYTM Health Care
- Exchange
- PBF Nasdaq
- RYTM Nasdaq
- Market Cap
- PBF 2.8B
- RYTM 4.3B
- IPO Year
- PBF 2012
- RYTM 2017
- Fundamental
- Price
- PBF $26.90
- RYTM $89.36
- Analyst Decision
- PBF Hold
- RYTM Strong Buy
- Analyst Count
- PBF 13
- RYTM 13
- Target Price
- PBF $25.25
- RYTM $88.77
- AVG Volume (30 Days)
- PBF 3.7M
- RYTM 968.7K
- Earning Date
- PBF 07-31-2025
- RYTM 08-05-2025
- Dividend Yield
- PBF 4.08%
- RYTM N/A
- EPS Growth
- PBF N/A
- RYTM N/A
- EPS
- PBF N/A
- RYTM N/A
- Revenue
- PBF $31,536,100,000.00
- RYTM $136,863,000.00
- Revenue This Year
- PBF N/A
- RYTM $37.56
- Revenue Next Year
- PBF $8.05
- RYTM $74.99
- P/E Ratio
- PBF N/A
- RYTM N/A
- Revenue Growth
- PBF N/A
- RYTM 48.88
- 52 Week Low
- PBF $13.62
- RYTM $40.61
- 52 Week High
- PBF $42.64
- RYTM $94.80
- Technical
- Relative Strength Index (RSI)
- PBF 65.89
- RYTM 78.63
- Support Level
- PBF $23.59
- RYTM $86.25
- Resistance Level
- PBF $29.17
- RYTM $94.80
- Average True Range (ATR)
- PBF 1.22
- RYTM 3.56
- MACD
- PBF 0.38
- RYTM 2.79
- Stochastic Oscillator
- PBF 72.22
- RYTM 84.00
About PBF PBF Energy Inc.
PBF Energy Inc is an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants, and other petroleum products in the United States. The company owns refineries in Delaware, Ohio, New Jersey, California, and Louisiana. The Company operates in two reportable business segments: Refining and Logistics. The Company's oil refineries are all engaged in the refining of crude oil and other feedstocks into petroleum products and are aggregated into the Refining segment. PBFX operates logistics assets such as crude oil and refined products terminals, pipelines and storage facilities. The Logistics segment consists solely of PBFX's operations.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.